Caitlin Rorke, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Route 35 Apt 1e, Point Pleasant, NJ 08742 Phone: 732-966-7057 |
News Archive
Researchers at Brown University and Women & Infants Hospital have invented the first artificial human ovary, an advance that provides a potentially powerful new means for conducting fertility research and could also yield infertility treatments for cancer patients. The team has already used the lab-grown organ to mature human eggs.
CAR T Cell Therapy is revolutionizing the field of hematologic malignancies and has the potential to achieve cure for a number of dreadful diseases.
It's a statistic that almost every healthcare facility knows: 40 percent of all healthcare-acquired infections are urinary tract infections (UTI). Since catheters - the most common source of these infections - are used on over four million hospital patients a year, the chances of a patient getting a UTI are pretty high. In fact, the daily risk for patients acquiring a urinary infection is as high as seven percent when indwelling urethral catheters remain in their original position.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
› Verified 7 days ago